Literature DB >> 29188412

Drug-related problems identified during geriatric medication review in the community pharmacy.

Mounir Rhalimi1,2, Alain Rauss3, Eric Housieaux4.   

Abstract

Background In line with the changing role of community pharmacists, we describe here a standardised procedure for detecting DRPs in elderly patients for use in community pharmacies. Objectives The primary aim was to describe the number and type of DRPs identified by community pharmacists in elderly patients. Secondary aims were to determine the number and type of associated pharmacist interventions (PIs) that were transmitted to the prescribers, and to identify risk factors associated with the occurrence of a PI. Setting Community pharmacies. Methods In this prospective, multicentre study, pharmacists received patients aged 65 and over. During a 30-min interview with patients who agreed to participate, patient characteristics were recorded such as age, weight, height, frailty (using the Short Emergency Geriatric Assessment grid), estimated renal function and compliance with treatment assessed by the Girerd scale. Main outcome measure DRPs characteristics. Results A total of 892 patients agreed to participate in 55 pharmacies. Among them 334 DRPs were identified and were associated with 259 PIs. Eighty-nine PIs of 259 were sent to the prescribing physicians; 70 (78%) were implemented by the general practitioner. Factors associated with the occurrence of a DRP are compliance problems [odds ratio (OR) = 1.8, 95% confidence interval (CI) (1.26-2.58)], frailty [OR = 1.3, 95% CI (1.01-1.66)], number of prescribed drugs per day [OR = 1.46, 95% CI (1.02-2.07)] and GFR < 60 mL/min [OR = 1.49, 95% CI (1.01-2.2)]. Conclusion This is the first standardised pharmaceutical assessment dedicated to the elderly carried out by community pharmacists in France. If implemented, it could help to find drug-related problems, identify frail elderly patients and ultimately decrease their exposure to iatrogenic medication errors.

Entities:  

Keywords:  Community pharmacy services; Drug-related problems; France; Geriatrics; Interprofessional relationships; Medication adherence; Medication review; Pharmacoepidemiology

Mesh:

Year:  2017        PMID: 29188412     DOI: 10.1007/s11096-017-0571-y

Source DB:  PubMed          Journal:  Int J Clin Pharm


  27 in total

Review 1.  Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

2.  Practical evaluation of the drug-related problem management process in Swiss community pharmacies.

Authors:  Jean-Marc Krähenbühl; Bertha Kremer; Bertrand Guignard; Olivier Bugnon
Journal:  Pharm World Sci       Date:  2008-04-06

3.  Trends in pharmacists' medication order review in French hospitals from 2006 to 2009: analysis of pharmacists' interventions from the Act-IP© website observatory.

Authors:  P Bedouch; N Sylvoz; B Charpiat; M Juste; R Roubille; F-X Rose; J-L Bosson; O Conort; B Allenet
Journal:  J Clin Pharm Ther       Date:  2014-10-10       Impact factor: 2.512

4.  [Assessment of antihypertensive compliance using a self-administered questionnaire: development and use in a hypertension clinic].

Authors:  X Girerd; O Hanon; K Anagnostopoulos; C Ciupek; J J Mourad; S Consoli
Journal:  Presse Med       Date:  2001 Jun 16-23       Impact factor: 1.228

5.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

6.  Drug-related problems in prescribed medicines in Germany at the time of dispensing.

Authors:  Andrea Nicolas; Christiane Eickhoff; Nina Griese; Martin Schulz
Journal:  Int J Clin Pharm       Date:  2013-04-20

7.  STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation.

Authors:  P Gallagher; C Ryan; S Byrne; J Kennedy; D O'Mahony
Journal:  Int J Clin Pharmacol Ther       Date:  2008-02       Impact factor: 1.366

Review 8.  Pharmacist services provided in general practice clinics: a systematic review and meta-analysis.

Authors:  Edwin C K Tan; Kay Stewart; Rohan A Elliott; Johnson George
Journal:  Res Social Adm Pharm       Date:  2013-10-23

9.  Designing health care for the most common chronic condition--multimorbidity.

Authors:  Mary E Tinetti; Terri R Fried; Cynthia M Boyd
Journal:  JAMA       Date:  2012-06-20       Impact factor: 56.272

10.  Cost-outcome description of clinical pharmacist interventions in a university teaching hospital.

Authors:  James Gallagher; Stephen Byrne; Noel Woods; Deirdre Lynch; Suzanne McCarthy
Journal:  BMC Health Serv Res       Date:  2014-04-17       Impact factor: 2.655

View more
  11 in total

1.  Mapping of drug-related problems among older adults conciliating medical and pharmaceutical approaches.

Authors:  Marie-Laure Laroche; Thi Hong Van Ngo; Caroline Sirois; Amélie Daveluy; Michel Guillaumin; Marie-Blanche Valnet-Rabier; Muriel Grau; Barbara Roux; Louis Merle
Journal:  Eur Geriatr Med       Date:  2021-03-20       Impact factor: 1.710

Review 2.  Medication use problems among older adults at a primary care: A narrative of literature review.

Authors:  Christina Christopher; Bhuvan Kc; Sunil Shrestha; Ali Qais Blebil; Deepa Alex; Mohamed Izham Mohamed Ibrahim; Norhasimah Ismail
Journal:  Aging Med (Milton)       Date:  2022-03-15

3.  Clinical impact of a pharmacist-led medication review with follow up for aged polypharmacy patients: A cluster randomized controlled trial.

Authors:  Raquel Varas-Doval; Miguel A Gastelurrutia; Shalom I Benrimoj; Victoria García-Cárdenas; Loreto Sáez-Benito; Fernando Martinez-Martínez
Journal:  Pharm Pract (Granada)       Date:  2020-10-21

4.  Role of the community pharmacist in detecting frailty and spatio-temporal disorientation among community-dwelling older people in France.

Authors:  Mounir Rhalimi; E Housieaux; A Mary; C Detuncq; A Muller; F Georgin; F Comby; C Wehrlé; N Davoust; M Brazier
Journal:  Aging Clin Exp Res       Date:  2020-08-04       Impact factor: 3.636

5.  Pharmaceutical Interventions on Hospital Discharge Prescriptions: Prospective Observational Study Highlighting Challenges for Community Pharmacists.

Authors:  Maria Dobrinas-Bonazzi; Nicolas Widmer; Sophie Grandchamp; Anne-Laure Blanc; Marine Roussel; Damien Tagan; Annelore Sautebin
Journal:  Drugs Real World Outcomes       Date:  2021-12-31

6.  'Modified STOPP-START criteria for Sri Lanka'; translating to a resource limited healthcare setting by Delphi consensus.

Authors:  N R Samaranayake; A Balasuriya; G H Fernando; D Samaraweera; L G T Shanika; J K P Wanigasuriya; C N Wijekoon; C A Wanigatunge
Journal:  BMC Geriatr       Date:  2019-10-22       Impact factor: 3.921

Review 7.  Adverse drug reactions in older adults: a narrative review of the literature.

Authors:  Maria Beatrice Zazzara; Katie Palmer; Davide Liborio Vetrano; Angelo Carfì; Graziano Onder
Journal:  Eur Geriatr Med       Date:  2021-03-18       Impact factor: 1.710

8.  Prevalence of adverse drug reactions in the primary care setting: A systematic review and meta-analysis.

Authors:  Widya N Insani; Cate Whittlesea; Hassan Alwafi; Kenneth K C Man; Sarah Chapman; Li Wei
Journal:  PLoS One       Date:  2021-05-26       Impact factor: 3.240

9.  Incidence, types and acceptability of pharmaceutical interventions about drug related problems in a general hospital: an open prospective cohort.

Authors:  Valdjane Saldanha; Rand Randall Martins; Sara Iasmin Vieira Cunha Lima; Ivonete Batista de Araujo; Antonio Gouveia Oliveira
Journal:  BMJ Open       Date:  2020-04-23       Impact factor: 2.692

10.  Prevalence and risk factors of drug-related problems identified in pharmacy-based medication reviews.

Authors:  Raphael Sell; Marion Schaefer
Journal:  Int J Clin Pharm       Date:  2020-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.